Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies decodes the immune system using next-gen sequencing to develop diagnostics and immune-driven therapeutics. Chart.
BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma focuses on genetic disease treatments, advancing a deep pipeline of targeted therapies for rare and underserved conditions. Chart.